UroGen Pharma to Present at Upcoming Investor Conferences

Author's Avatar
Mar 01, 2023

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will present at the following investor conferences in March: